Ontario Ministry of Health rejects family’s application for Phase 1 trial of donor-derived Car T-cell treatment in the U.S. for their 17-year-old son. December 17, 2019December 19, 2019Dr. Barry Dworkin Medical Mythbusting Commentary for December 17, 2019 [display_podcast] Source:‘This might be our last Christmas together’: family rejected by Ontario government after requesting cancer treatment in United States Related posts: CAR-T therapy has its successes for treating leukemias and other blood cancers but please do not sell it in press releases with testimonials that do not cite the serious side effects of treatment. Case studies reported in Nature of decade-long leukaemia remissions after CAR T treatment. #GoScience Nanoparticle technology offers promising treatment for triple negative metastatic breast cancer. Human trials to follow in 2017 Were breast cancer screening guidelines based on a flawed Canadian study? Principle investigators refute allegation made by researchers from reputable institutions who will have their commentary published this week in the Journal of Medical Screening. Car-Tleukemia